{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:15:12Z","timestamp":1792430112848,"version":"4.5.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["K.B. is funded through the Rosetrees Trust, Stoney"],"award-info":[{"award-number":["K.B. is funded through the Rosetrees Trust, Stoney"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["VPR's salary is funded by the Rosetrees Trust"],"award-info":[{"award-number":["VPR's salary is funded by the Rosetrees Trust"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lithium monotherapy has been recommended as first-line maintenance or long-term pharmacological therapy for bipolar disorder (BD). Previous research has linked early lithium use with better outcomes for people with BD. Despite extensive evidence as an effective treatment for BD, lithium prescribing continues to decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>Our primary aim was to determine the time between initial assessment by mental health services and lithium initiation in people with BD who were prescribed and concordant with lithium. Secondary objectives included determining the time between the first assessment and recorded BD diagnosis, number of prior mood episodes, polarity when lithium was prescribed and number of antipsychotics before lithium initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Free-text clinical notes were extracted from a de-identified electronic health record database. Eligible records comprised adults with a BD diagnosis who were concordant with lithium treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Eighty-eight people were identified, based on inclusion and exclusion criteria. Median time between first assessment and lithium initiation was 659\u2009days. Median time between first assessment and BD diagnosis was 220\u2009days, with a median of 2.5 mood episodes and 2 antipsychotics prescribed prior to lithium. Around 30% of people presented with manic symptoms at the time of lithium prescription. There is a significant delay between first contact with services and initiation of lithium in people with BD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This highlights the potential for earlier intervention with lithium, which could improve outcomes for people with BD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02698811251408749","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T04:39:25Z","timestamp":1771043965000},"page":"945-950","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Time to lithium: A case register study of lithium initiation in bipolar disorder"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2485-3054","authenticated-orcid":false,"given":"Violeta","family":"Perez-Rodriguez","sequence":"first","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry Psychology &amp; Neuroscience, King\u2019s College London, UK"},{"name":"TREAT Service, South London and Maudsley NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Schmack Lab, The Francis Crick Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2769-8237","authenticated-orcid":false,"given":"Katherine","family":"Beck","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry Psychology &amp; Neuroscience, King\u2019s College London, UK"},{"name":"TREAT Service, South London and Maudsley NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4366-3835","authenticated-orcid":false,"given":"Emma","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry Psychology &amp; Neuroscience, King\u2019s College London, UK"},{"name":"TREAT Service, South London and Maudsley NHS Foundation Trust, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-8788","authenticated-orcid":false,"given":"Rashmi","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2984-1124","authenticated-orcid":false,"given":"Rebecca","family":"Strawbridge","sequence":"additional","affiliation":[{"name":"Centre for Affective Disorders, Institute of Psychiatry Psychology &amp; Neuroscience, King\u2019s College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Howes","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry Psychology &amp; Neuroscience, King\u2019s College London, UK"},{"name":"TREAT Service, South London and Maudsley NHS Foundation Trust, UK"},{"name":"Department of Brain Sciences, Imperial College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2291-6952","authenticated-orcid":false,"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences, Imperial College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3878-3659","authenticated-orcid":false,"given":"Sameer","family":"Jauhar","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences, Imperial College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"e_1_3_2_2_1","author":"American Psychiatric Association (APA)","year":"2002","unstructured":"American Psychiatric Association (APA) (2002) Practice Guideline for the Treatment of Patients With Bipolar Disorder.","journal-title":"Practice Guideline for the Treatment of Patients With Bipolar Disorder"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.116.186833"},{"key":"e_1_3_2_4_1","volume-title":"British National Formulary (BNF) 80","author":"BMJ Group","year":"2020","unstructured":"BMJ Group (2020) British National Formulary (BNF) 80. BMJ Group and Pharmaceutical Press."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.07.062"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2020.06.017"},{"key":"e_1_3_2_7_1","first-page":"180","article-title":"The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines","volume":"20","author":"Fountoulakis KN","year":"2016","unstructured":"Fountoulakis KN, Grunze H, Vieta E, et al. (2016) The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines. International Journal of Neuropsychopharmacology 20: 180\u2013195.","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116636545"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622970209150612"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-023-00301-y"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.111.105833"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-019-0145-0"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-015-0557-z"},{"issue":"2","key":"e_1_3_2_14_1","article-title":"Clinical guidance on the identification and management of treatment-resistant schizophrenia","volume":"80","author":"Kane JM","year":"2019","unstructured":"Kane JM, Agid O, Baldwin ML, et al. (2019) Clinical guidance on the identification and management of treatment-resistant schizophrenia. Journal of Clinical Psychiatry 80(2): 18com12123.","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"e_1_3_2_15_1","first-page":"344","article-title":"The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence","volume":"21","author":"Keramatian K","year":"2023","unstructured":"Keramatian K, Chithra NK, Yatham LN (2023) The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence. Focus (American Psychiatric Publishing) 21(4): 344\u2013353.","journal-title":"Focus (American Psychiatric Publishing)"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-023-00322-7"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.142802"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2019.16"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13299"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867420979353"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12942"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-023-00310-x"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2017.02.067"},{"key":"e_1_3_2_24_1","unstructured":"MHRA (2023) National Patient Safety Alert: Valproate: Organisations to prepare for new regulatory measures for oversight of prescribing to new patients and existing female patients (NatPSA\/2023\/013\/HMRA). Available at: https:\/\/www.gov.uk\/drug-device-alerts\/national-patient-safety-alert-valproate-organisations-to-prepare-for-new-regulatory-measures-for-oversight-of-prescribing-to-new-patients-and-existing-female-patients-natpsa-slash-2023-slash-013-slash-mhra (accessed 1 October 2025)."},{"key":"e_1_3_2_25_1","author":"National Institute for Health and Care Excellence (NICE)","year":"2023","unstructured":"National Institute for Health and Care Excellence (NICE) (2023) Bipolar Disorder: Assessment and Management.","journal-title":"Bipolar Disorder: Assessment and Management"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2021.08.264"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126530"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008721"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-022-00275-3"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.19091000"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13490"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852924002311"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251408749","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02698811251408749","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02698811251408749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:16:39Z","timestamp":1783746999000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02698811251408749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1177\/02698811251408749"],"URL":"https:\/\/doi.org\/10.1177\/02698811251408749","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}